Xtant Medical Holdings
XTNT
19 hedge funds and large institutions have $54.8M invested in Xtant Medical Holdings in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
21% more capital invested
Capital invested by funds: $45.2M → $54.8M (+$9.62M)
0.69% less ownership
Funds ownership: 92.93% → 92.24% (-0.69%)
14% less funds holding
Funds holding: 22 → 19 (-3)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$46.1K |
| 2 |
MPPLM
Midwest Professional Planners Ltd (MPPL)
Wausau,
Wisconsin
|
+$26.7K |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$6.54K |
| 4 |
State Street
Boston,
Massachusetts
|
+$567 |
| 5 |
APA
American Portfolios Advisors
Holbrook,
New York
|
+$190 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$36.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$25K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$16.4K |
| 5 |
VF
Virtu Financial
New York
|
-$16.1K |
XTNT Hedge Fund Activity: Q1 2022 in Review
19 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q1 2022, worth a combined $54.8M — up 21% from $45.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of XTNT and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was OrbiMed, adding an estimated $46.1K. The largest seller was Renaissance Technologies, cutting an estimated $36.3K.
- 19 institutional investors held Xtant Medical Holdings (XTNT) as of Q1 2022, down from 22 in Q4 2021.
- Funds reported $54.8M of Xtant Medical Holdings stock for Q1 2022, up 21% quarter-over-quarter.
- 3 funds opened new Xtant Medical Holdings positions in Q1 2022 and 6 closed out, a net change of -3 holders.
- The largest Xtant Medical Holdings buyer in Q1 2022 was OrbiMed, an estimated $46.1K added.
- The largest Xtant Medical Holdings seller in Q1 2022 was Renaissance Technologies, an estimated $36.3K sold.
Based on aggregated 13F filings for Q1 2022.